Israel Chemicals Ltd (ICL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 327,000 | 420,000 | 417,000 | 473,000 | 214,000 |
| Marketable Securities | 115,000 | 172,000 | 91,000 | 91,000 | 153,000 |
| Receivables | 1,260,000 | 1,376,000 | 1,583,000 | 1,775,000 | 1,224,000 |
| Inventories | 1,626,000 | 1,703,000 | 2,134,000 | 1,570,000 | 1,250,000 |
| TOTAL | $3,586,000 | $4,034,000 | $4,548,000 | $3,909,000 | $2,841,000 |
| Non-Current Assets | |||||
| PPE Net | 6,462,000 | 6,329,000 | 5,969,000 | 5,754,000 | 5,550,000 |
| Investments And Advances | 0 | 0 | 0 | 0 | 83,000 |
| Intangibles | 869,000 | 873,000 | 852,000 | 867,000 | 670,000 |
| Other Non-Current Assets | 404,000 | 391,000 | 381,000 | 550,000 | 520,000 |
| TOTAL | $7,735,000 | $7,593,000 | $7,202,000 | $7,171,000 | $6,823,000 |
| Total Assets | $11,321,000 | $11,627,000 | $11,750,000 | $11,080,000 | $9,664,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 384,000 | 858,000 | 512,000 | 577,000 | 679,000 |
| Accounts payable and accrued liabilities | 1,881,000 | 1,695,000 | 2,013,000 | 1,976,000 | 740,000 |
| Other current liabilities | 63,000 | 85,000 | 81,000 | 59,000 | 758,000 |
| TOTAL | $2,328,000 | $2,638,000 | $2,606,000 | $2,612,000 | $2,177,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,909,000 | 1,829,000 | 2,312,000 | 2,436,000 | 2,053,000 |
| Other Non-Current Liabilities | 559,000 | 594,000 | 636,000 | 863,000 | 1,007,000 |
| TOTAL | $3,006,000 | $2,952,000 | $3,431,000 | $3,732,000 | $3,399,000 |
| Total Liabilities | $5,334,000 | $5,590,000 | $6,037,000 | $6,344,000 | $5,576,000 |
| Shareholders' Equity | |||||
| Common Shares | 549,000 | 549,000 | 549,000 | 548,000 | 546,000 |
| Retained earnings | 5,764,000 | 5,583,000 | 5,385,000 | 4,321,000 | 3,752,000 |
| Other shareholders' equity | -463,000 | -216,000 | -321,000 | -235,000 | -176,000 |
| TOTAL | $5,987,000 | $6,037,000 | $5,713,000 | $4,736,000 | $4,088,000 |
| Total Liabilities And Equity | $11,321,000 | $11,627,000 | $11,750,000 | $11,080,000 | $9,664,000 |